Clinical Supply Chain Prevention Case Study: Closing Critical Gaps

Anthony Torres, Sr. Manager, Clinical Supplies, CSC

By Anthony Torres
Sr. Manager, Clinical Supplies


At Clinical Supply Consulting (CSC), we specialize in transforming how pharmaceutical, biotech, and medical device companies manage their clinical supply chains. Through our case studies, you’ll discover how our innovative solutions can help you overcome challenges, boost efficiency, and fast-track your time to market.

The Challenge

A sponsor with a multi-phase clinical program involving complex compounds approached CSC during a critical transition period. Internal turnover had created an immediate need for supply chain expertise while they evaluated new vendors. With plans to expand their global footprint across sites and depots, the sponsor faced multiple operational challenges that threatened study timelines and patient care. The situation demanded a comprehensive review of their supply chain processes and immediate intervention to prevent further complications.

Key Challenges:

  • Critical clinical supply chain and forecasting gaps required immediate attention
  • Forecast reliability compromised by missing Interactive Response Technology (IRT) parameters
  • Qualified person (QP) and country release times exceeded three months
  • Ongoing stockouts affected patient and site management
  • IRT system required complete restructuring to improve data integrity
  • Unnecessarily high distribution costs due to operational inefficiencies

The Solution

By focusing on creating integrated solutions that addressed immediate operational issues while building a foundation for long-term success, CSC implemented a strategic overhaul of the clinical supply chain. This comprehensive approach brought together key stakeholders and streamlined critical processes, establishing a more efficient and sustainable supply chain model.

Key Solutions:

  • Developed new forecasting paradigm with refined inputs and more reliable data
  • Facilitated collaboration between chemistry manufacturing and control (CMC), quality assurance (QA), and manufacturing vendors to reduce timelines
  • Updated IRT specifications to minimize overage/waste and improve data capture
  • Streamlined distribution processes to reduce operational costs
  • Implemented improved site and depot management strategies

The Results


Scroll to Top